Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Are Naive to Biologic DMARD Therapy

Condition:   Psoriatic Arthritis Interventions:   Drug: Filgotinib;   Drug: Adalimumab;   Drug: Placebo to match filgotinib;   Drug: Placebo to match adalimumab Sponsors:   Gilead Sciences;   Galapagos NV Not yet recruiting

Source: ClinicalTrials.gov - October 4, 2019 Category: Research Source Type: clinical trials